Navidea Biopharmaceuticals Inc. -Investors

Business Units and Joint Ventures. Annual Meeting and Proxy. Corporate Ethics and Conduct. Data as of 080715 400 pm ET. Minimum 20 minute delay. Annual Meeting and Proxy. Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance. Navidea Awarded 1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept in Rheumatoid Arthritis. Navidea and Massachusetts General Hospital to Evaluate Manocept for Detection of Cardiovascular Disease with NIH Grant.

OVERVIEW

The website ir.navidea.com currently has an average traffic classification of zero (the smaller the more traffic). We have crawled zero pages within the site ir.navidea.com and found fourteen websites linking to ir.navidea.com.
Links to this site
14

IR.NAVIDEA.COM TRAFFIC

The website ir.navidea.com has seen variant amounts of traffic throughout the the year.
Traffic for ir.navidea.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.navidea.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.navidea.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO IR.NAVIDEA.COM

Navidea Biopharmaceuticals, Inc. NAVB

Navidea Envisions a World Where Disease can be Precisely Identified and Treated. The Sale of Lymphoseek to Cardinal Health. Navidea Future Outlook and Trial Outcome Call.

WHAT DOES IR.NAVIDEA.COM LOOK LIKE?

Desktop Screenshot of ir.navidea.com Mobile Screenshot of ir.navidea.com Tablet Screenshot of ir.navidea.com

IR.NAVIDEA.COM SERVER

I detected that a single root page on ir.navidea.com took zero milliseconds to stream. We could not discover a SSL certificate, so in conclusion our crawlers consider ir.navidea.com not secure.
Load time
0 sec
SSL
NOT SECURE
IP
52.52.165.211

SITE TITLE

Navidea Biopharmaceuticals Inc. -Investors

DESCRIPTION

Business Units and Joint Ventures. Annual Meeting and Proxy. Corporate Ethics and Conduct. Data as of 080715 400 pm ET. Minimum 20 minute delay. Annual Meeting and Proxy. Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance. Navidea Awarded 1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept in Rheumatoid Arthritis. Navidea and Massachusetts General Hospital to Evaluate Manocept for Detection of Cardiovascular Disease with NIH Grant.

PARSED CONTENT

The website ir.navidea.com has the following in the site, "Data as of 080715 400 pm ET." I analyzed that the website also stated " Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance." They also stated "7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept in Rheumatoid Arthritis. Navidea and Massachusetts General Hospital to Evaluate Manocept for Detection of Cardiovascular Disease with NIH Grant."

SEE OTHER WEBSITES

Navios Maritime Acquisition Corp - Investor Relations -Investor Overview

The Company is publicly traded on the New York Stock Exchange under the ticker â œNNA. There are currently no events scheduled. Navios Group Closes Second Transaction With HSH Nordbank AG. Acquired 14 Vessels With Fair Market Value o.

Ì ÃÇÏ ÀÎÅÍݪߪ! ÀÎÅÍÝóÀÇ ÁßÉÀÌ µÇÚÀÏÙ.

Á È ºÆà ºñ º Á á È. ÇÁ Î ð Ç È ºÆà ºñ º Á á È. 2018 â ÈÞ í ÅÍ î µ È. IPV6 ç Á á Î ÀÎÇÑ IPV6 È ºÆà óÇ . KR µµ ÞÀÎ ÀÏ ý â ü ÀÌÀü µû ÜÀÌ.

Apache Tomcat

Congratulations! As you may have guessed by now, this is the default Tomcat home page. For more detailed setup and administration information than is found in the INSTALL file. For developers working on Tomcat.

National Dong Hwa University Institutional Repository主頁

0 Powered By DSPACE, MIT. Enhanced by NTU Library IR team. National Dong Hwa University Institutional Repository 主頁.

About Us Nektar Therapeutics

US Medicines Marketed by Our Partners. EU Medicines Marketed by Our Partners. Scientific and Clinical Data Presentations. Benefits at San Francisco, California. Benefits at Huntsville, Alabama. Benefits at Hyderabad, India. Our unique research and development pipeline of new investigational medicines in cancer, pain and immunology. Our team of dedicated scientists, clinicians and e.